Shrey Kanvinde
Overview
Explore the profile of Shrey Kanvinde including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
91
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kanvinde S, Deodhar S, Kulkarni T, Jogdeo C
BioTech (Basel)
. 2023 May;
12(2).
PMID: 37218751
There have been significant collaborative efforts over the past three years to develop therapies against COVID-19. During this journey, there has also been a lot of focus on understanding at-risk...
2.
Jogdeo C, Panja S, Kanvinde S, Kapoor E, Siddhanta K, Oupicky D
Adv Healthc Mater
. 2022 Dec;
12(7):e2202400.
PMID: 36453542
Combination therapy targeting multiple therapeutic targets is a favorable strategy to achieve better therapeutic outcomes in cancer and inflammatory diseases. Codelivery is a subfield of drug delivery that aims to...
3.
Kanvinde S, Kulkarni T, Deodhar S, Bhattacharya D, Dasgupta A
BioTech (Basel)
. 2022 Jul;
11(1).
PMID: 35822814
The research and development of non-viral gene therapy has been extensive over the past decade and has received a big push thanks to the recent successful approval of non-viral nucleic...
4.
Chhonker Y, Kanvinde S, Ahmad R, Singh A, Oupicky D, Murry D
Metabolites
. 2021 Mar;
11(2).
PMID: 33673198
Eicosanoids are key mediators and regulators of inflammation and oxidative stress that are often used as biomarkers for severity and therapeutic responses in various diseases. We here report a highly...
5.
Kanvinde S, Chhonker Y, Ahmad R, Yu F, Sleightholm R, Tang W, et al.
Acta Biomater
. 2018 Oct;
82:158-170.
PMID: 30342282
Inflammatory bowel disease is a chronic inflammation of the gastrointestinal tract with poor understanding of its pathogenesis and no effective cure. The goal of this study was to evaluate the...
6.
Wani A, Savithra G, Abyad A, Kanvinde S, Li J, Brock S, et al.
Sci Rep
. 2017 May;
7(1):2274.
PMID: 28536462
Mesoporous silica nanomaterials show great potential to deliver chemotherapeutics for cancer treatment. The key challenges in the development of injectable mesoporous silica formulations are colloidal instability, hemolysis and inefficient drug...
7.
Zhu Y, Li J, Kanvinde S, Lin Z, Hazeldine S, Singh R, et al.
Mol Pharm
. 2014 Aug;
12(2):332-41.
PMID: 25153488
Polycations are explored as carriers to deliver therapeutic nucleic acids. Polycations are conventionally pharmacological inert with the sole function of delivering therapeutic cargo. This study reports synthesis of a self-immolative...
8.
Roggers R, Kanvinde S, Boonsith S, Oupicky D
AAPS PharmSciTech
. 2014 May;
15(5):1163-71.
PMID: 24871552
Mesoporous silica nanoparticles (MSNs) have been proposed as drug delivery devices for approximately 15 years. The history of in vitro studies has been promising, demonstrating that MSNs have the capability...